Boit C F David has filed its latest 13F-HR report with the SEC, revealing a total value of $240.96 million in holdings as of September 30, 2026. This filing is crucial as it provides insights into the firm's investment strategy and portfolio adjustments in a competitive financial landscape.

The filing highlights key positions in major companies, including 3M Company, Abbott Laboratories, and Apple Inc. This indicates a focus on established, high-value stocks that are likely to contribute to long-term growth. Such strategic investments may reflect the firm's confidence in these companies' market positions and future prospects.

Background

Boit C F David is an investment management firm based in Boston, Massachusetts. The firm is known for its strategic investments in a diverse range of companies. According to the latest filings, it has consistently reported its holdings through the 13F-HR forms, with the most recent submission dated October 29, 2026. The firm operates under the SEC Act of 1934.

What the Filing Says

The 13F-HR filing, accession number 0001308331-26-000010, states that Boit C F David holds a total of 108 different securities with a combined value of $240,962,266. The report includes information on the number of shares held for each security, the value of those shares, and the investment discretion exercised by the firm.

Impact

This filing may affect various stakeholders, including investors, analysts, and competitors in the investment management sector. By disclosing its holdings, Boit C F David provides transparency that can influence market perceptions and investment strategies among peers. Additionally, the report may serve as a benchmark for other firms in the industry.

What's Next

The filing does not say what happens next. However, it is anticipated that Boit C F David will continue to adjust its portfolio in response to market conditions and investment opportunities.